Literature DB >> 22395451

Simultaneous analysis of plasma and CSF by NMR and hierarchical models fusion.

Agnieszka Smolinska1, Joram M Posma, Lionel Blanchet, Kirsten A M Ampt, Amos Attali, Tinka Tuinstra, Theo Luider, Marek Doskocz, Paul J Michiels, Frederic C Girard, Lutgarde M C Buydens, Sybren S Wijmenga.   

Abstract

Because cerebrospinal fluid (CSF) is the biofluid which interacts most closely with the central nervous system, it holds promise as a reporter of neurological disease, for example multiple sclerosis (MScl). To characterize the metabolomics profile of neuroinflammatory aspects of this disease we studied an animal model of MScl-experimental autoimmune/allergic encephalomyelitis (EAE). Because CSF also exchanges metabolites with blood via the blood-brain barrier, malfunctions occurring in the CNS may be reflected in the biochemical composition of blood plasma. The combination of blood plasma and CSF provides more complete information about the disease. Both biofluids can be studied by use of NMR spectroscopy. It is then necessary to perform combined analysis of the two different datasets. Mid-level data fusion was therefore applied to blood plasma and CSF datasets. First, relevant information was extracted from each biofluid dataset by use of linear support vector machine recursive feature elimination. The selected variables from each dataset were concatenated for joint analysis by partial least squares discriminant analysis (PLS-DA). The combined metabolomics information from plasma and CSF enables more efficient and reliable discrimination of the onset of EAE. Second, we introduced hierarchical models fusion, in which previously developed PLS-DA models are hierarchically combined. We show that this approach enables neuroinflamed rats (even on the day of onset) to be distinguished from either healthy or peripherally inflamed rats. Moreover, progression of EAE can be investigated because the model separates the onset and peak of the disease.

Entities:  

Mesh:

Year:  2012        PMID: 22395451      PMCID: PMC3336062          DOI: 10.1007/s00216-012-5871-4

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  25 in total

Review 1.  Blood-brain barrier disruption in multiple sclerosis.

Authors:  Alireza Minagar; J Steven Alexander
Journal:  Mult Scler       Date:  2003-12       Impact factor: 6.312

2.  Rapid Production of Acute Disseminated Encephalomyelitis in Rhesus Monkeys by Injection of Brain Tissue With Adjuvants.

Authors:  E A Kabat; A Wolf; A E Bezer
Journal:  Science       Date:  1946-10-18       Impact factor: 47.728

3.  Multivariate modeling and prediction of breast cancer prognostic factors using MR metabolomics.

Authors:  Guro F Giskeødegård; Maria T Grinde; Beathe Sitter; David E Axelson; Steinar Lundgren; Hans E Fjøsne; Steinar Dahl; Ingrid S Gribbestad; Tone F Bathen
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

4.  Metabolomics of cerebrospinal fluid reveals changes in the central nervous system metabolism in a rat model of multiple sclerosis.

Authors:  Marek J Noga; Adrie Dane; Shanna Shi; Amos Attali; Hans van Aken; Ernst Suidgeest; Tinka Tuinstra; Bas Muilwijk; Leon Coulier; Theo Luider; Theo H Reijmers; Rob J Vreeken; Thomas Hankemeier
Journal:  Metabolomics       Date:  2011-04-16       Impact factor: 4.290

5.  MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis.

Authors:  D H Miller; I E Ormerod; A Gibson; E P du Boulay; P Rudge; W I McDonald
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

6.  Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid.

Authors:  Paola Sarchielli; Laura Greco; Ardesio Floridi; Alessandro Floridi; Virgilio Gallai
Journal:  Arch Neurol       Date:  2003-08

7.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

8.  Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases.

Authors:  F Monaco; S Fumero; A Mondino; R Mutani
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-07       Impact factor: 10.154

9.  Evidence that tyrosine phosphorylation may increase tight junction permeability.

Authors:  J M Staddon; K Herrenknecht; C Smales; L L Rubin
Journal:  J Cell Sci       Date:  1995-02       Impact factor: 5.285

10.  THE ANTIBODY RESPONSE OF RABBITS TO INJECTIONS OF EMULSIONS AND EXTRACTS OF HOMOLOGOUS BRAIN.

Authors:  F F Schwentker; T M Rivers
Journal:  J Exp Med       Date:  1934-10-31       Impact factor: 14.307

View more
  6 in total

1.  Profiling of volatile organic compounds in exhaled breath as a strategy to find early predictive signatures of asthma in children.

Authors:  Agnieszka Smolinska; Ester M M Klaassen; Jan W Dallinga; Kim D G van de Kant; Quirijn Jobsis; Edwin J C Moonen; Onno C P van Schayck; Edward Dompeling; Frederik J van Schooten
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 2.  NMR Techniques in Metabolomic Studies: A Quick Overview on Examples of Utilization.

Authors:  Joanna Kruk; Marek Doskocz; Elżbieta Jodłowska; Anna Zacharzewska; Joanna Łakomiec; Kornelia Czaja; Jacek Kujawski
Journal:  Appl Magn Reson       Date:  2016-11-02       Impact factor: 0.831

Review 3.  An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview.

Authors:  Insha Zahoor; Bin Rui; Junaid Khan; Indrani Datta; Shailendra Giri
Journal:  Cell Mol Life Sci       Date:  2021-01-15       Impact factor: 9.261

4.  (1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis.

Authors:  Eleonora Cocco; Federica Murgia; Lorena Lorefice; Luigi Barberini; Simone Poddighe; Jessica Frau; Giuseppe Fenu; Giancarlo Coghe; Maria Rita Murru; Raffaele Murru; Francesco Del Carratore; Luigi Atzori; Maria Giovanna Marrosu
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-12-24

Review 5.  Metabolomics in Autoimmune Diseases: Focus on Rheumatoid Arthritis, Systemic Lupus Erythematous, and Multiple Sclerosis.

Authors:  Naeun Yoon; Ah-Kyung Jang; Yerim Seo; Byung Hwa Jung
Journal:  Metabolites       Date:  2021-11-29

6.  The use of exhaled air analysis in discriminating interstitial lung diseases: a pilot study.

Authors:  L Plantier; A Smolinska; R Fijten; M Flamant; J Dallinga; J J Mercadier; D Pachen; M P d'Ortho; F J van Schooten; B Crestani; A W Boots
Journal:  Respir Res       Date:  2022-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.